Following a February 2025 executive order targeting federal bureaucracy, the Trump administration has dissolved more than one hundred independent advisory committees across key United States government agencies, fundamentally altering the mechanisms through which outside experts guide national biomedical and environmental research priorities. This sweeping reduction in external oversight coincides with the termination of thousands of research grants and the elimination of tens of thousands of federal scientific workforce positions over the past year, according to a comprehensive Nature analysis published on April 28, 2026.
The Department of Health and Human Services disbanded seventy-seven advisory boards in 2025, representing more than one-quarter of its total external panels and marking a stark departure from historical norms, given that annual terminations have exceeded ten only once since 1997. Operating under the Federal Advisory Committee Act, these dismantled groups previously provided specialized guidance on critical public health and scientific domains across multiple federal agencies, including:
Among the most prominent casualties of this restructuring was the Dietary Guidelines Advisory Committee, whose sudden absence allowed the federal government to issue new nutritional recommendations in January without the standard scientific consensus that typically underpins such national health directives. The administration defended the abrupt dismissal of the National Science Foundation board members last week by citing the 2021 Supreme Court case United States v. Arthrex, Inc., arguing that the lack of Senate confirmation for these external experts raised significant constitutional questions regarding their regulatory authority.
Beyond outright terminations, the federal government has sharply curtailed the transparency of remaining scientific panels by reducing the number of open meetings where the public can observe deliberations by more than fifty percent at certain agencies. At the Department of Health and Human Services specifically, the number of publicly accessible committee meetings plummeted from a ten-year average of two hundred and fifty-five down to just ninety-one in 2025, driving the ratio of open to closed sessions from over nine percent to a mere four percent.
In instances where committees survived the initial wave of cuts, such as the highly influential Advisory Committee on Immunization Practices that makes recommendations on vaccines, federal officials drastically altered the membership composition by removing dissenting voices and installing personnel who align with the administration’s current policy stances. White House spokesperson Kush Desai defended these comprehensive overhauls by stating that the historical surplus of taxpayer-funded advisory boards failed to generate meaningful policy insights, asserting instead that the administration is prioritizing efficiency over redundant bureaucratic structures.
Researchers and former agency officials caution that this massive reduction in external advisory capacity severs a vital conduit for independent expertise, effectively isolating federal policymakers from the broader scientific community and private sector organizations that represent patients with complex diseases like Alzheimer’s. Juan Meza, an applied mathematician at the University of California, Merced, who formerly served on two disbanded panels at the National Science Foundation and the Department of Energy, notes that these committees allowed scientists to act as ambassadors in both directions between the government and the public.
Carrie Wolinetz, who previously administered several advisory panels as the former head of the National Institutes of Health science-policy office, warns that diminishing the number of these advisory panels fundamentally degrades the operational transparency of the federal scientific apparatus. White House representatives firmly rebutted these claims, arguing that the February 2025 executive order successfully curtails government waste, lowers inflation, and advances American freedom by streamlining operations during the post-pandemic era.
The Trump Administration is eliminating the bureaucratic bloat and taking a hands-on approach to ensure that policymaking is driven by Gold Standard Science.
Ian Simon, the former head of the recently eliminated Department of Health and Human Services Office of Long COVID Research and Practice, emphasizes that the disbanded long COVID committee was specifically structured to elevate patient perspectives to the same level as those of clinical researchers and attending physicians. Simon argues that the sudden closure of this specialized panel represents a severe blow to ongoing clinical research and patient advocacy efforts across the nation.
It is very hard to see how these actions will advance the work that’s needed to understand long COVID and other infectious chronic conditions.
As federal agencies continue to operate under the constraints of the February 2025 executive order, the scientific community will be closely monitoring how the National Institutes of Health and other departments manage their remaining advisory boards, particularly those that have historically met frequently but are now convening less often or not at all. The administration’s stated goal of updating the law to ensure the National Science Foundation board performs its duties as Congress intended suggests that further legislative or structural overhauls to federal science oversight are imminent.
Without the standardized input of the Dietary Guidelines Advisory Committee and the Advisory Committee on Organ Transplantation, upcoming federal health directives will likely face intense scrutiny from medical professionals concerned about the bypassing of established scientific consensus. Ultimately, the permanent shift toward closed-door grant reviews and internal policymaking will force academic institutions and biomedical researchers to adapt to a highly centralized system of federal funding and regulatory guidance in the coming years.
